个人化膝关节植入物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球个人化膝关节植入物市场价值为 25 亿美元，预计到 2034 年将以 6.1% 的复合年增长率增长至 46 亿美元。骨关节炎和其他退化性关节疾病的发生率不断上升，尤其是在老年人群中，这推动了对客製化膝关节假体的需求。由于传统植入物难以满足个别患者的精确需求，个人化膝关节植入物越来越受欢迎。这些植入物采用 CT 和 MRI 扫描等先进影像技术製造，可透过客製化方法恢復自然关节运动，同时最大限度地减少术后併发症。 3D 列印技术的兴起彻底改变了製造工艺，使植入物能够更精确地与患者独特的解剖结构对齐，从而提高舒适度、更好地对齐并延长耐用性。

此外，随着患者日益要求根据自身需求量身定制、注重疗效的医疗保健解决方案，这种日益增长的偏好正成为市场扩张的关键驱动力。个人化治疗不仅能提高患者满意度，还能透过针对每位患者的独特状况和解剖因素来改善长期健康结果。随着3D影像和精准手术等医疗技术的进步，医疗服务提供者现在可以提供更个人化、有效的干预措施，以满足每位患者的特定健康状况。这种向个人化护理的转变反映了医疗保健行业的更广泛趋势：患者正在寻求能够带来显着改善、更短康復时间和更高成功率的治疗方案。

个人化膝关节植入物市场的主要细分市场在2024年创收12亿美元。这一类别通常包括针对晚期骨关节炎患者的首次膝关节置换手术。由于人口老化、肥胖率上升和损伤事件增多，全球骨关节炎盛行率不断上升，这显着增加了对首次膝关节置换手术的需求。此外，为了保留关节功能并防止进一步残疾，医生术后转诊的增加也推动了这个细分市场的成长。美国、德国、日本和澳洲等医疗体系健全的国家受益于公共和私人保险政策，这些政策涵盖了这些治疗的费用，进一步支持了该市场的扩张。

预计到2034年，金属-塑胶植入物市场的复合年增长率将达到5.7%。金属-塑胶植入物比金属-金属和陶瓷植入物更经济实惠，尤其适合公共医疗系统和新兴市场，因为这些市场的成本和可负担性是关键因素。此外，高交联聚乙烯 (HXLPE) 和维生素E改性聚乙烯的开发增强了塑胶植入物的耐磨性，解决了其传统的缺陷之一。这些进步正在延长植入物的使用寿命，改善患者的治疗效果，进而推动市场进一步成长。

2024年，美国个人化膝关节植入物市场规模达7.79亿美元。患者意识的提升、可支配收入的增加以及医疗保健解决方案需求的不断增长等因素，共同推动美国个人化膝关节植入物市场的成长。越来越多的患者，尤其是活跃人群，寻求舒适度更高、恢復更快、疗效更持久的客製化膝关节植入物。这种需求促使骨科中心投资3D列印技术和病患客製化植入物等基础设施。此外，由于全膝关节置换术等手术已纳入联邦医疗保险（Medicare）、医疗补助（Medicaid）和私人保险的覆盖范围，市场也得到了报销计划的进一步支持。

全球个人化膝关节植入物市场的主要参与者包括 DePuySynthes、Zimmer Biomet、Medacta、Conformis、B Braun、Globus Medica 和 Restor3D。个人化膝关节植入物市场的公司专注于技术创新，例如结合 3D 列印技术来生产高度客製化的植入物，从而提供更佳的对准度和更长的使用寿命。许多公司也与医院和骨科中心合作，提供更具针对性的治疗方案，以改善患者的治疗效果。透过加强研发力度，各公司正在研发不仅能满足患者特定需求，还能帮助缩短復健时间并提高术后生活品质的植入物。该领域的参与者正致力于透过材料和製造技术的进步来提高其产品的价格承受能力。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 骨关节炎和膝关节退化盛行率上升
    • 3D列印和成像技术的进步
    • 机器人和人工智慧辅助膝关节手术的成长
    • 个人化医疗解决方案需求激增
  • 产业陷阱与挑战
    • 手术费用高且报销有限
    • 发展中市场准入受限
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按程序 2021 – 2034

• 主要趋势
• 基本的
• 部分的
• 修订

第六章：市场估计与预测：按类型，2021 年至 2034 年

• 主要趋势
• 股骨
• 胫骨
• 髌骨

第七章：市场估计与预测：按材料，2021 年至 2034 年

• 主要趋势
• 金属与塑料
• 陶瓷-塑料
• 金属对金属
• 陶瓷对陶瓷

第 8 章：市场估计与预测：按固定材料，2021 年至 2034 年

• 主要趋势
• 骨水泥
• 非骨水泥
• 杂交种

第九章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第十章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• B BRAUN
• Conformis
• DePuySynthes
• Globus Medica
• Medacta
• restor3D
• Zimmer Bionet

The Global Personalized Knee Implants Market was valued at USD 2.5 billion in 2024 and is estimated to grow at a CAGR of 6.1% to reach USD 4.6 billion by 2034. The increasing incidence of osteoarthritis and other degenerative joint diseases, particularly among older populations, is fueling demand for customized knee prosthetics. As traditional implants struggle to meet the precise needs of individual patients, personalized knee implants have become increasingly popular. These implants, which are created using advanced imaging techniques like CT and MRI scans, offer a tailored approach to restoring natural joint movement while minimizing postoperative complications. The rise of 3D printing technology has revolutionized the manufacturing process, allowing for implants that align more accurately with the patient's unique anatomy, resulting in improved comfort, better alignment, and longer-lasting durability.

Moreover, as patients increasingly demand healthcare solutions that are tailored to their individual needs and focus on achieving better outcomes, this growing preference is becoming a key driver for the market's expansion. Personalized treatments not only enhance patient satisfaction but also improve long-term health results by addressing the unique conditions and anatomical factors of each patient. With advances in medical technology, such as 3D imaging and precision surgery, providers can now offer more customized, effective interventions that align with each patient's specific health profile. This shift toward personalized care reflects broader trends in the healthcare industry, where patients are seeking treatments that deliver measurable improvements, shorter recovery times, and higher success rates.

The primary segment in the personalized knee implants market generated USD 1.2 billion in 2024. This category typically includes first-time knee replacement surgeries for patients suffering from advanced osteoarthritis. The increasing global prevalence of osteoarthritis, driven by an aging population, rising obesity rates, and higher injury incidents, is contributing significantly to the demand for primary knee replacement procedures. Additionally, a rise in postoperative referrals from physicians, aiming to preserve joint function and prevent further disability, is also boosting this segment's growth. Countries with robust healthcare systems, such as the U.S., Germany, Japan, and Australia, benefit from public and private insurance policies that cover the costs of these treatments, further supporting this market's expansion.

The metal-on-plastic segment is anticipated to grow at a CAGR of 5.7% through 2034. Metal-on-plastic implants are more affordable than their metal-on-metal and ceramic counterparts, making them particularly suitable for public healthcare systems and emerging markets, where cost and affordability are key factors. Furthermore, the development of highly cross-linked polyethylene (HXLPE) and polyethylene modified by vitamin E has enhanced the wear resistance of plastic implants, addressing one of their traditional shortcomings. These advancements are leading to longer implant lifespans and better patient outcomes, driving further market growth.

U.S. Personalized Knee Implants Market was valued at USD 779 million in 2024. Factors such as growing patient awareness increased disposable incomes, and rising demand for healthcare solutions are driving market growth in the U.S. Patients are increasingly seeking custom knee implants that offer better comfort, faster recovery, and longer-lasting results, especially among active individuals. This demand has pushed orthopedic centers to invest in infrastructure such as 3D printing technologies and patient-specific implants. Additionally, with procedures like total knee arthroplasty being covered by Medicare, Medicaid, and private insurance, the market is further supported by reimbursement programs.

Key players in the Global Personalized Knee Implants Market include DePuySynthes, Zimmer Biomet, Medacta, Conformis, B Braun, Globus Medica, and Restor3D. Companies in the personalized knee implants market are focusing on technological innovations, such as incorporating 3D printing to produce highly customized implants that offer better alignment and longevity. Many companies are also partnering with hospitals and orthopedic centers offering more tailored treatment solutions to improve patient outcomes. By enhancing their research and development efforts, companies are creating implants that not only meet patient-specific needs but also help reduce recovery times and post-surgical quality of life. Players in this space are working to improve the affordability of their products through advancements in materials and manufacturing techniques.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of osteoarthritis and knee degeneration
    • 3.2.1.2 Technological advancements in 3D printing and imaging
    • 3.2.1.3 Growth in robotic and AI-assisted knee surgery
    • 3.2.1.4 Surging demand for personalised healthcare solutions
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost and limited reimbursement for the procedure
    • 3.2.2.2 Limited access in developing markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Procedure 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Primary
• 5.3 Partial
• 5.4 Revision

Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Femoral
• 6.3 Tibia
• 6.4 Patella

Chapter 7 Market Estimates and Forecast, By Material, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Metal-on-plastic
• 7.3 Ceramic-on-plastic
• 7.4 Metal-on-metal
• 7.5 Ceramic-on-ceramic

Chapter 8 Market Estimates and Forecast, By Fixation Material, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Cemented
• 8.3 Cementless
• 8.4 Hybrid

Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Ambulatory surgical centers
• 9.4 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 B BRAUN
• 11.2 Conformis
• 11.3 DePuySynthes
• 11.4 Globus Medica
• 11.5 Medacta
• 11.6 restor3D
• 11.7 Zimmer Bionet